Rabbit Recombinant Monoclonal YTHDF1 antibody. Carrier free. Suitable for Flow Cyt (Intra), ICC/IF, IP, WB and reacts with Rat, Mouse, Human samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
Flow Cyt (Intra) | ICC/IF | IP | WB | IHC-P | |
---|---|---|---|---|---|
Human | Tested | Tested | Tested | Tested | Not recommended |
Mouse | Tested | Tested | Tested | Tested | Not recommended |
Rat | Tested | Not recommended | Expected | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Rat, Mouse, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Specifically recognizes and binds N6-methyladenosine (m6A)-containing mRNAs, and regulates their stability (PubMed:24284625, PubMed:26318451, PubMed:32492408). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing (PubMed:24284625, PubMed:32492408). Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT complex (PubMed:32492408). The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) shares m6A-containing mRNAs targets and act redundantly to mediate mRNA degradation and cellular differentiation (PubMed:28106072, PubMed:32492408). Required to facilitate learning and memory formation in the hippocampus by binding to m6A-containing neuronal mRNAs (By similarity). Acts as a regulator of axon guidance by binding to m6A-containing ROBO3 transcripts (By similarity). Acts as a negative regulator of antigen cross-presentation in myeloid dendritic cells (By similarity). In the context of tumorigenesis, negative regulation of antigen cross-presentation limits the anti-tumor response by reducing efficiency of tumor-antigen cross-presentation (By similarity). Promotes formation of phase-separated membraneless compartments, such as P-bodies or stress granules, by undergoing liquid-liquid phase separation upon binding to mRNAs containing multiple m6A-modified residues: polymethylated mRNAs act as a multivalent scaffold for the binding of YTHDF proteins, juxtaposing their disordered regions and thereby leading to phase separation (PubMed:31292544, PubMed:31388144, PubMed:32451507). The resulting mRNA-YTHDF complexes then partition into different endogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules (PubMed:31292544).
YTHDF2, YTHDF3
C20orf21, YTHDF1, YTH domain-containing family protein 1, DF1, Dermatomyositis associated with cancer putative autoantigen 1, DACA-1
Rabbit Recombinant Monoclonal YTHDF1 antibody. Carrier free. Suitable for Flow Cyt (Intra), ICC/IF, IP, WB and reacts with Rat, Mouse, Human samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
YTHDF1 YTHDF2 and YTHDF3 also known as YTH domain family proteins are key readers of N6-methyladenosine (m6A) RNA modifications. These proteins each weigh around 63-68 kDa and show expression across various human tissues with notable activity in the brain and liver. YTHDF proteins bind to m6A-modified RNAs facilitating subsequent RNA metabolism processes such as translation and decay. By recognizing m6A marks YTHDF1 2 and 3 influence RNA fate therefore playing an important role in post-transcriptional gene regulation.
YTHDF proteins facilitate the dynamic control of mRNA stability and translation efficiency. They are known to interact with each other forming complexes that further strengthen their functional impact on RNA targets. In particular YTHDF1 enhances translation by recruiting ribosomes to m6A-modified mRNAs. YTHDF2 primarily targets mRNA for degradation therefore reducing mRNA stability. Meanwhile YTHDF3 supports both YTHDF1-mediated translation and YTHDF2-mediated degradation acting as a versatile mediator in RNA regulation.
These proteins play important roles in cellular homeostasis and stress responses. The m6A modification pathway involves collaboration with proteins such as METTL3 and FTO which add and remove m6A marks respectively. The interaction of YTHDF proteins within this pathway allows cells to quickly respond to stimuli by adjusting protein production levels. Their functions align with signaling pathways like the mTOR pathway where they influence translation rates in response to nutrient availability.
YTHDF proteins are linked to cancers and neurological conditions. Dysregulation of these proteins associates with tumorigenesis particularly through interactions with oncogenic proteins such as c-Myc. Abnormal YTHDF function also connects to neurodegenerative disorders where alterations in mRNA metabolism lead to neural dysfunction. The ability of YTHDF proteins to bind specific m6A-modified mRNAs makes them targets for therapeutic intervention in these diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734, the same antibody clone in a different buffer formulation.
Blocking / Diluent buffer and concentration:5% NFDM/TBST.
Lysates should be made freshly and used in WB immediately to minimize protein degradation.
All lanes: Western blot - Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] (Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734) at 1/1000 dilution
Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate. at 20 µg
Lane 2: 293T (human embryonic kidney epithelial cell) whole cell lysate. at 20 µg
Lane 3: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate. at 20 µg
Lane 4: PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate. at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 61 kDa
Exposure time: 70s
This data was developed using Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734, the same antibody clone in a different buffer formulation.
Blocking / Diluting buffer and concentration: 5% NFDM/TBST
All lanes: Western blot - Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] (Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734) at 1/1000 dilution
Lane 1: His-tagged human YTHDF1 recombinant protein 10ng
Lane 2: His-tagged human YTHDF2 recombinant protein 10ng
Lane 3: His-tagged human YTHDF3 recombinant protein 10ng
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/50000 dilution
Observed band size: 61 kDa
Exposure time: 70s
This data was developed using Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeilized HeLa (human cervix adenocarcinoma epithelial cell) cells lebelling YTHDF1 + YTHDF2 + YTHDF3 with Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 at 1/50 (10.04 ug/ml) dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2ug/mL) dilution (Green). Confocal image showing mostly cytoplasmic staining in Hela cell line is observed. Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5ug/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2ug/mL) dilution.
This data was developed using Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734, the same antibody clone in a different buffer formulation.
YTHDF1 + YTHDF2 + YTHDF3 was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast) whole cell lysate 10 ug with Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate 10 ug
Lane 2: Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 IP in NIH/3T3 whole cell lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 in NIH/3T3 whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 15 seconds
All lanes: Immunoprecipitation - Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] (Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734)
This data was developed using ab290749, the same antibody clone in a different buffer formulation.
YTHDF1 + YTHDF2 + YTHDF3 was immunoprecipitated from 0.35 mg HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10 ug Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using anti YTHDF1 + YTHDF2 + YTHDF3 antibody (Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734) at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg
Lane 2: anti YTHDF1 + YTHDF2 + YTHDF3 antibody (Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734) IP in HeLa whole cell lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 in HeLa whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 15 seconds
All lanes: Immunoprecipitation - Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] (Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734)
This data was developed using Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeilized NIH/3T3 (mouse embryonic fibroblast) cells lebelling YTHDF1 + YTHDF2 + YTHDF3 with Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 at 1/50 (10.04 ug/ml) dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2ug/mL) dilution (Green). Confocal image showing cytoplasmic staining in NIH/3T3 cell line is observed. Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5ug/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2ug/mL) dilution.
This data was developed using Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HeLa (Human cervix adenocarcinoma epithelial cell) cells labelling YTHDF1 + YTHDF2 + YTHDF3 with Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081) at 1/2000 dilution was used as the secondary antibody.
This data was developed using Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734, the same antibody clone in a different buffer formulation.
Intracellular flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized NIH/3T3 (Mouse embryonic fibroblast) cells labelling YTHDF1 + YTHDF2 + YTHDF3 with Anti-YTHDF1 + YTHDF3 + YTHDF2 antibody [EPR26183-69] ab290734 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081) at 1/2000 dilution was used as the secondary antibody.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com